FDA Probes Minds: Comment on Behavioral Health Data Collection
Published Date: 2/18/2026
Notice
Summary
The FDA is asking for approval to keep collecting information that helps them understand how people think and behave about health topics. This info guides their decisions and communications, affecting patients, healthcare pros, and consumers. Comments on this plan are open until March 20, 2026, with no new costs expected.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 0 costs, 2 mixed.
Research Covers Drug Safety and Misinformation
FDA will use these social and behavioral methods to study topics including nonmedical use of approved drugs; use of unapproved and falsified (counterfeit) drug products; use of botanical substances (e.g., cannabis-derived products); controlled substance prescribing decisions; bystander response to drug overdoses; and potentially false or misleading information about drug products. These studies are meant to gather perceptions and behaviors from specific target populations to inform whether further research or action is needed.
FDA Keeps Running Short Health Surveys
The FDA asked OMB to renew a data collection that supports about 25 social and behavioral studies per year. The collection estimates 126,770 responses annually at 0.25 hours (15 minutes) each, totaling 31,693 hours per year, an increase of 17,300 responses and 4,325 hours versus the prior estimate; patients, healthcare professionals, and consumers may be asked to take these short interviews or surveys.
No Respondent Monetary Costs Expected
FDA states there are no capital costs or operating and maintenance costs associated with this information collection. The Agency does not expect respondents to incur monetary costs from participating in these surveys and interviews.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12167 — Andrew Jonathan Morgan: Final Debarment Order
Andrew Jonathan Morgan is officially banned for 5 years from importing any drugs into the U.S. because he was convicted of a serious crime related to drug importation. He didn’t respond to the FDA’s notice, so the ban started on June 17, 2026, and he can apply to end it anytime. This means no drug imports from him for a while, keeping things safe and legal.
2026-12165 — Medical Devices; Gastroenterology-Urology Devices; Classification of the Ingestible Gastrointestinal Blood Detection Capsule
The FDA is officially putting the ingestible gastrointestinal blood detection capsule into Class II, meaning it now has special safety rules but fewer hurdles than before. This change helps patients get access to this cool, innovative device faster and keeps it safe and effective. The new classification is effective June 17, 2026, and could save time and money for makers and users alike.
2026-12166 — Medical Devices; Radiology Devices; Classification of the Radiological Machine Learning-Based Quantitative Imaging Software With Predetermined Change Control Plan
The FDA is officially putting radiology software that uses machine learning and has a set plan for updates into a safer, easier-to-manage category called Class II. This change helps make sure the software is safe and effective while speeding up patient access to cool new tech. It’s been effective since early 2023, so companies can expect fewer hoops to jump through without extra costs or delays.
2026-11966 — Forms FDA 3542a and FDA 3542: Questions and Answers; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help businesses fill out Forms FDA 3542a and FDA 3542 without confusion. If you submit these forms, this guide answers your top questions and makes the process smoother. You’ve got until August 14, 2026, to send in your feedback before the FDA finalizes the guide—no extra costs, just clearer steps!
2026-11998 — Amendment and Revocation of Organizational Information Regulations
The FDA is updating its rules to point everyone to its website for the latest contact and organizational info, ditching old, unnecessary regulations. This makes it easier for the public to find accurate info all in one place, starting June 15, 2026. If you interact with the FDA, expect smoother access with no extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
Previous / Next Documents
Previous: 2026-03098 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco To Protect Children and Adolescents
The FDA is asking for feedback on rules that keep cigarettes and smokeless tobacco away from kids and teens. Tobacco makers, sellers, and advertisers must tell the FDA if they plan to use new types of ads or labels not already approved. Comments are open until March 20, 2026, and this helps make sure tobacco stays out of young hands without adding extra costs.
Next: 2026-03100 — Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for your thoughts on their National HIV Surveillance System forms to make sure they’re useful and not too much work. They’re giving everyone 30 more days to share ideas before the final review, aiming to keep things clear and easy while saving time and money. If you’re involved or just curious, now’s the time to speak up!